HEALTHSOUTH Reports Strong Revenue And Earnings Growth For Fourth Quarter 2016 And Reiterates Full-Year 2017 Guidance Post author:Sam Post published:February 21, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Roche Launches The Cobas EGFR Mutation Test V2 For Use With Either Plasma Or Tumor Tissue Samples March 13, 2017 Siemens Healthineers And HeartFlow Collaborate To Provide Solution That Has Potential To Lower Cardiac Care Costs March 16, 2017 Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017
Roche Launches The Cobas EGFR Mutation Test V2 For Use With Either Plasma Or Tumor Tissue Samples March 13, 2017
Siemens Healthineers And HeartFlow Collaborate To Provide Solution That Has Potential To Lower Cardiac Care Costs March 16, 2017
Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017